Luigi Taranto Montemurro

Luigi Taranto Montemurro has a diverse work experience spanning multiple companies and roles. Luigi is currently serving as the Chief Scientific Officer at Apnimed since February 2021 and previously held the position of Medical Director from February 2020 to February 2021 at the same company.

Prior to joining Apnimed, Montemurro worked at Brigham and Women's Hospital, starting as a Postdoctoral Fellow from January 2015 to October 2017. Luigi then served as an Associate Scientist from October 2017 to February 2020.

In addition, Montemurro has been involved with Apnimed, Inc. as a scientific founder and advisor from June 2018 to February 2020. Luigi also worked as an Instructor In Medicine at Harvard Medical School from October 2017 to February 2020.

Before joining the healthcare and medical research field, Montemurro gained experience as a Scientific Consultant at Cambridge Sound Management from December 2016 to June 2017 and at Novion Pharmaceutical from April 2016 to December 2016.

Their earlier work experience includes roles such as Dirigente Medico Pneumologia at A.O. Mellino Mellini from October 2011 to January 2015 and as a Libero professionista pneumologo at FERB Trescore-Ospedale S.Isidoro from August 2011 to August 2012.

Luigi Taranto Montemurro has an extensive education history. Luigi started their education at Liceo A Calini Brescia, but no specific degree or field of study is mentioned.

Luigi then attended the Università degli Studi di Brescia from 2000 to 2006, where they earned a Laurea in Medicina e Chirurgia, although the field of study is unspecified.

In 2007, Luigi pursued further specialization at the Università degli Studi di Brescia and obtained a degree as Specialista in Malattie dell'Apparato Respiratorio. Again, the field of study is not specified.

Continuing their education, Luigi completed a Post-Doc Research Fellowship at the University of Toronto from 2010 to 2011, focusing on Sleep Medicine and Cardiovascular Diseases.

From 2009 onwards, they obtained a specialization as a Specialista in Medicina del Sonno from the Associazione Italiana di Medicina del Sonno, although the start date is not mentioned.

Luigi then joined the Harvard Medical School in 2015 and completed a Post-doc Research Fellowship on Sleep Medicine and Circadian Disorders, which lasted until 2017.

Additionally, in October 2020, they obtained a certification in Biomedical Research Investigators and Key Personnel from the CITI Program, A Division of BRANY.

Overall, Luigi Taranto Montemurro has pursued an educational path focused on medicine, particularly in the fields of sleep medicine, respiratory diseases, and cardiovascular diseases, in renowned institutions such as Harvard Medical School and the University of Toronto.